Editors' ChoiceParkinson’s Disease

In on the ground floor: T cells respond to α-synuclein in preclinical Parkinson’s disease

See allHide authors and affiliations

Science Translational Medicine  20 May 2020:
Vol. 12, Issue 544, eabb7100
DOI: 10.1126/scitranslmed.abb7100


Analysis of peripheral blood mononuclear cells demonstrated that α-synuclein–specific T cells are active in preclinical and early Parkinson’s disease.

View Full Text

Stay Connected to Science Translational Medicine